SEOM clinical guidelines to primary prevention of cancer (2018)

por Bayo, J., Molina, R., Pérez, J., Pérez-Ruíz, E., Aparicio, J., Beato, C., Berros, J. P., Bolaños, M., Graña, B., Santaballa, A.
Publicado 2019

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

por Feliu, J, Salud, A, Escudero, P, Lopez-Gómez, L, Bolaños, M, Galán, A, Vicent, J-M, Yubero, A, Losa, F, De Castro, J, de Mon, M Á, Casado, E, González-Barón, M
Publicado 2006

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

por Feliu, J, Safont, M J, Salud, A, Losa, F, García-Girón, C, Bosch, C, Escudero, P, López, R, Madroñal, C, Bolaños, M, Gil, M, Llombart, A, Castro-Carpeño, J, González-Barón, M
Publicado 2010